Amarin highlights Vascepa cost advantage over new injectable rivals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. ONON
6. RTB
7. AAPL
8. RARE
9. BA
10. ACN

Go back to Amarin highlights Vascepa cost advantage over new injectable rivals
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 13.63 --0 (-0%)
Previous Close $13.63    52 Week High $3.65 
Open $13.63    52 Week Low $1.24 
Day High $13.63    P/E N/A 
Day Low $13.63    EPS $0.00 
Volume 192